Vikram Sheel Kumar

Vikram Sheel Kumar (born 1976) is an American engineer, doctor, and entrepreneur.

Vikram Sheel Kumar
Born
United States
EducationEngineering
Alma materIndian Institute of Technology, Columbia University, Harvard-MIT Division of Health Sciences
Occupationengineer, doctor, entrepreneur
Parent(s)
  • Vijay Sheel Kumar[1] (father)

Early life and education

Vikram Kumar was born in the United States to an Indian-American family. His father was a neurosurgeon. As a child, the family returned to India, where Kumar attended the Modern School in New Delhi. After graduation, he studied engineering at the Indian Institute of Technology.

In 1996, Kumar returned to the United States, and received a BS in operations research from Columbia University in 1999. He then studied medicine and business at the Harvard-MIT Division of Health Sciences and Technology, which was supported by The Paul & Daisy Soros Fellowships for New Americans.

Career

In 2002, Kumar co-founded Dimagi, a for-profit software company which develops open-source software technology for doctors in impoverished areas. Kumar currently serves as the company's Chief Medical Officer (CMO). He also co-founded Cogito Corp, a startup which uses a mobile-phone based voice analysis system to determine the mental health patterns of patients, and Ozorie, which manufactures pain relief, rapid heal, and hair revival products.

In 2004, Technology Review named him one of the world's top 100 innovators under 35 in biotechnology and medicine, and awarded him the "Technology in the Service of Humanity" award. In 2005, he received the Ten Outstanding Young Americans (TOYA) award.

In 2007, Kumar completed a residency as a clinical pathologist at Brigham and Women's Hospital. He then returned to India to help his ailing father, who owned Doctor Kares Hospital, a super-specialty hospital in New Delhi, manage his business. While in India, Kumar also founded another startup. After his father's death, he returned to Boston to better manage Dimagi.

In 2017, Kumar co-founded Clear Creek Bio to develop a DHODH inhibitor, called brequinar, for leukemia. The company is also studying brequinar as an oral antiviral for SARS-CoV-2. Kumar currently serves as the CEO of Clear Creek Bio. As of now, he lives in Boston, with his wife and two children.

References
  1. "Dr.Vikram Sheel Kumar: What Keeps Us Going | Forbes India". Forbes India. Retrieved 18 January 2018.


This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.